top of page
Helaina raises $45m to speed-up commercialisation of human bioactive proteins
Helaina has raised $45 million in a Series B funding round led by investment firm Avidity Partners.
breast milk
The Cell Base is your one-stop shop for all cell-based news – helping you keep your finger on the pulse with the latest business updates and technological insights.
bottom of page